SuperHeart bio-cyber multi-heart system pumps blood or Superblood (ex-vivo mass produced blood components culture), in external supplementation as with Neurobot, Exosuit and/or Permanent Life Module platforms, or in internal supplementation, as Neurobot second organ set donation to supplement and regenerate natural heart.
Multi-heart system with larger upper/lower thorax hearts for upper/lower blood circulation and smaller supplementation hearts, head, left/right arms/legs, all with the possibility of receiving blood/Superblood oxygenation, nutrition, supplementation internally and/or externally.
All cells from segments of body, specially head/brain, can be protected by any temporary electric failure, vascular obstruction or heart failure and achieve higher performance as for physical resistance and regeneration. The current primitive abandonment of human body with +99,99% of living cells because of a heart dysfunction can be automatically avoided, even now current techniques, as manual/machine CPR Cardiopulmonary Resuscitation and heart-lung machines.
Organs/tissues regenerated by cell mitosis division, lower regeneration capacity with genetic hormonal decline, including telomerase decline leading to reduction of telomere DNA cap increasing cell dysfunction senescent/cancer cells, also decline in immune cells.They can receive general growth stimulation from hormones, enzymes, proteins as telomerase to increase DNA cap telomeres and avoid development of dysfunctional cells as senescent/cancer cells. But non-telomere dysfunction cancer as genetic/environmental/substance abuse cancer occurs, this supplementation can accelerate cancer cell growth as well, requiring immune supplementation to block it and healthy cell supplementation or regeneration to compete for nutrition and space with cancer cells.
Organs/tissues that are less/slow regenerative as Heart/Brain cells, because of their particular function, can also be induced to self-regeneration process to repair themselves using mRNA/microRNA (transcription factors/stem cell messenger exosomes to return the cells to a stem-cell-like state), contained in lipid membranes as they occur in nature inside micro lipid cell membranes. High risk/high cost organ transplant can generate rejection because of DNA difference detected by immune system or immune vulnerability if using anti-immunity agents. Introducing external tissue/cells/stem cells that may generate uneven masses/tumors/teratomas, tissue/organ growth dysfunction as left ventricular valve can happen with excessive, uncoordinated late general hormone decline supplementation.
PERMANENT LIFE TECHNOLOGY